PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,906,226 | -20.4% | 2,023,836 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $26,278,628 | -9.4% | 2,004,472 | -22.8% | 0.00% | 0.0% |
| Q1 2023 | $29,012,245 | +42.2% | 2,595,013 | +7.2% | 0.00% | 0.0% |
| Q4 2022 | $20,397,397 | -61.2% | 2,419,620 | -23.2% | 0.00% | -50.0% |
| Q3 2022 | $52,509,000 | +13.8% | 3,151,742 | +0.6% | 0.00% | +100.0% |
| Q2 2022 | $46,124,000 | -28.9% | 3,133,510 | +19.8% | 0.00% | -50.0% |
| Q1 2022 | $64,916,000 | -19.8% | 2,616,519 | +3.6% | 0.00% | 0.0% |
| Q4 2021 | $80,961,000 | -8.2% | 2,524,488 | +3.0% | 0.00% | 0.0% |
| Q3 2021 | $88,227,000 | +5.9% | 2,452,115 | +29.9% | 0.00% | 0.0% |
| Q2 2021 | $83,311,000 | +59.5% | 1,888,275 | +65.4% | 0.00% | +100.0% |
| Q1 2021 | $52,219,000 | -31.1% | 1,141,640 | +3.9% | 0.00% | -50.0% |
| Q4 2020 | $75,836,000 | – | 1,098,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |